Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli resigned as the head of Turing Pharmaceuticals, one of the companies he runs, and another, KaloBios Pharmaceuticals, said Dec. 21, in a printed statement that it terminated Shkreli last week.
Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli resigned as the head of Turing Pharmaceuticals, one of the companies he runs, and another, KaloBios Pharmaceuticals, said Dec. 21, in a printed statement that it terminated Shkreli last week. Craig Ruttle The Associated Press File
Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli resigned as the head of Turing Pharmaceuticals, one of the companies he runs, and another, KaloBios Pharmaceuticals, said Dec. 21, in a printed statement that it terminated Shkreli last week. Craig Ruttle The Associated Press File

Editorial: Dose of karma for ‘pharma bro’ Martin Shkreli

December 23, 2015 6:28 AM

More Videos

  • Around Donald Trump in the first 100 days

    Take a tour with Bee editorial cartoonist SW Parra of President Trump's up and downs during his first 100 days in office.